Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Sarcoma 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Myelodysplastic Syndromes 120Leukemia, Myeloid, Acute 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Hodgkin Disease 70Leukemia 67Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Non-Hodgkin 63Multiple Myeloma 59Myeloproliferative Disorders 57Lymphoma 54Leukemia, Myelogenous, Chronic, BCR-ABL Positive 47Leukemia, Myeloid, Accelerated Phase 46Lymphoma, Follicular 44Leukemia, Myelomonocytic, Chronic 44Leukemia, Myeloid, Chronic-Phase 44Congenital Abnormalities 43Lymphoma, Mantle-Cell 42Primary Myelofibrosis 41Lymphoma, Large B-Cell, Diffuse 41Lymphoma, B-Cell, Marginal Zone 39Burkitt Lymphoma 36Blast Crisis 36Graft vs Host Disease 35Neoplasms, Plasma Cell 34Lymphoma, Large-Cell, Immunoblastic 32Myelodysplastic-Myeloproliferative Diseases 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Waldenstrom Macroglobulinemia 21Lymphoma, T-Cell, Cutaneous 20Anemia, Refractory, with Excess of Blasts 20

Interventions

X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Flow Cytometry 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Biopsy 5Therapeutics 4Methylprednisolone 4Cyclophosphamide 4Radiotherapy 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Immunologic Techniques 3Antilymphocyte Serum 3Amplified Fragment Length Polymorphism Analysis 3ulixertinib 2trametinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2liposomal amphotericin B 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2dabrafenib 2Voriconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Tacrolimus × Myeloid × Clear all
NCT00109993 2010-06-11

Campath-1H + FK506 and Methylprednisolone for GVHD

Case Comprehensive Cancer Center

Phase 2 Completed
34 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡